Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Two new managers join Clondalkin Group
Two new managers join Clondalkin Group
With a combined experience of 55 years in the packaging sector
Luciano Rossetti to become EVP of R&D at Merck Serono
Luciano Rossetti to become EVP of R&D at Merck Serono
Takes up the position, based in Billerica, MA, US on 21 July
Tadahiro Matsumura joins Catalent as Country Leader in Japan
Tadahiro Matsumura joins Catalent as Country Leader in Japan
Will drive growth through business development in Japan and the surrounding area
Oxford BioTherapeutics hires Head of Clinical Development
Oxford BioTherapeutics hires Head of Clinical Development
Dr Eugen Leo takes the position
Mitie Group appoints manufacturing specialist for its Environmental+ business
Mitie Group appoints manufacturing specialist for its Environmental+ business
Gareth Smallman becomes Director of Manufacturing, Industrial and Specialist Services
Biotec Services appoints Martin Lamb as Commercial Director
Biotec Services appoints Martin Lamb as Commercial Director
He has more than 20 years of industry experience
Winners of the Chemical Industry Awards 2014 announced
Winners of the Chemical Industry Awards 2014 announced
Novartis and GSK are honoured
Aesica recruits Business Development Manager
Aesica recruits Business Development Manager
Nadine Reuter will help drive sales in Germany, Austria and Switzerland
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Dr Sarah Harris will lead the team in San Diego
C4X Discovery appoints Piers Morgan as Chief Executive
C4X Discovery appoints Piers Morgan as Chief Executive
Succeeds Sam Williams who returns to Non-Executive Director role
Solstice Biologics expands management team following achievement of technology milestones
Solstice Biologics expands management team following achievement of technology milestones
Appoints Lou Tartaglia as President and CEO, while John Borgeson joins as CFO
Robbie Stewart and Jen Doody join PCI UK team
Robbie Stewart and Jen Doody join PCI UK team
New appointments in Business Development and Human Resource Management
Oxford BioTherapeutics appoints Chief Scientific Officer
Oxford BioTherapeutics appoints Chief Scientific Officer
Dr Keith Wilson joins the company from AbbVie
ViroCyt strengthens management team
ViroCyt strengthens management team
Cellular and molecular immunologist joins the company as Chief Technology Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Ronald Marcus joins the Australian-US biotechnology company
Biovision announces the winners of the Catalyzer and Investor Conference awards
Biovision announces the winners of the Catalyzer and Investor Conference awards
This year’s focus was on finance and innovation
Previous
1
…
124
125
126
127
(current)
128
129
130
…
213
Next
Trending Articles
MasterControl strengthens executive leadership team with two key appointments
Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Ardena appoints Ariane de Ganck as Chief Scientific Officer
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as Chief Scientific Officer
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all